Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2.
暂无分享,去创建一个
[1] M. Sapp,et al. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. , 1995, The Journal of general virology.
[2] P. Schirmacher,et al. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells , 1995, Journal of virology.
[3] J. Walboomers,et al. Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. , 1994, The Journal of general virology.
[4] Darren W. Henderson,et al. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins , 1994, Journal of virology.
[5] R. Reichman,et al. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. , 1994, The Journal of general virology.
[6] M. Hagensee,et al. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids , 1994, Journal of virology.
[7] P. Schirmacher,et al. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. , 1994, Virology.
[8] D. Lowy,et al. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. , 1994, Journal of the National Cancer Institute.
[9] I. Frazer,et al. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence , 1994, Journal of virology.
[10] D. Lowy,et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles , 1993, Journal of virology.
[11] M. Hagensee,et al. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. , 1993, Virology.
[12] G. Grindlay,et al. Prophylactic and therapeutic vaccination against a mucosal papillomavirus. , 1993, The Journal of general virology.
[13] R. Garcea,et al. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles , 1993, Journal of virology.
[14] M. Sapp,et al. Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33 , 1993, Journal of virology.
[15] M. Hagensee,et al. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins , 1993, Journal of virology.
[16] D. Lowy,et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Shah,et al. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. , 1992, The Journal of general virology.
[18] D. Galloway,et al. Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 , 1992, Journal of virology.
[19] Y. L. Lin,et al. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. , 1992, Virology.
[20] T. Baker,et al. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. , 1991, Biophysical journal.
[21] I. Frazer,et al. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. , 1991, Virology.
[22] R. Burk,et al. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins. , 1991, Virology.
[23] N. Christensen,et al. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. , 1991, Virology.
[24] D. Galloway,et al. Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18 , 1991, Journal of virology.
[25] M. Dunn,et al. Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions , 1991, Journal of virology.
[26] N. Christensen,et al. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11 , 1990, Journal of virology.
[27] D. Galloway,et al. Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. , 1990, Virology.
[28] E. de Villiers. Heterogeneity of the human papillomavirus group , 1989, Journal of virology.
[29] E. Villiers. Heterogeneity of the human papillomavirus group. , 1989 .
[30] A. B. Jenson,et al. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. , 1989, The Journal of general virology.
[31] P. Lake,et al. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. , 1987, Journal of the National Cancer Institute.
[32] J. Doorbar,et al. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a , 1987, Journal of virology.
[33] H. Shirasawa,et al. Expression of the human papillomavirus type 6b L2 open reading frame in Escherichia coli: L2-beta-galactosidase fusion proteins and their antigenic properties. , 1987, Virology.
[34] F. Breitburd,et al. The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens , 1986, Journal of virology.
[35] S. Cole,et al. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer , 1986, Journal of virology.
[36] C. Milstein,et al. Antibodies to major histocompatibility antigens produced by hybrid cell lines , 1977, Nature.